Article

Right bundle branch block and long-term mortality in patients with acute congestive heart failure

Universitätsspital Basel, Bâle, Basel-City, Switzerland
Journal of Internal Medicine (Impact Factor: 6.06). 12/2006; 260(5):421-8. DOI: 10.1111/j.1365-2796.2006.01703.x
Source: PubMed

ABSTRACT

Risk stratification in acute congestive heart failure (ACHF) is poorly defined. The aim of the present study was to assess the impact of right bundle brunch block (RBBB) on long-term mortality in patients presenting with ACHF.
The initial 12-lead electrocardiogram was analysed for RBBB in 192 consecutive patients presenting with ACHF to the emergency department. The primary endpoint was all-cause mortality during 720-day follow-up. This study included an elderly cohort (mean age 74 years) of ACHF patients. RBBB was present in 27 patients (14%). Age, sex, B-type natriuretic peptide levels and initial management were similar in patients with RBBB when compared with patients without RBBB. However, patients with RBBB more often had pulmonary comorbidity. A total of 84 patients died during follow-up. Kaplan-Meier analysis revealed that mortality at 720 days was significantly higher in patients with RBBB when compared with patients without RBBB (63% vs. 39%, P = 0.004). In Cox proportional hazard analysis, RBBB was associated with a two-fold increase in mortality (hazard ratio 2.18, 95% CI 1.26-3.66; P = 0.003). This association persisted after adjustment for age and comorbidity.
RBBB is a powerful predictor of mortality in patients with ACHF. Early identification of this high-risk group may help to offer tailored treatment in order to improve outcome.

Download full-text

Full-text

Available from: Tobias Breidthardt, Jan 15, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Hospitalization for heart failure is associated with high postdischarge mortality and morbidity. The predictive value of the QRS duration during admission for heart failure has not been well studied. To investigate the predictive value of the QRS duration in patients hospitalized for heart failure with reduced left ventricular ejection fraction (LVEF). Retrospective, post hoc analysis from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST), an event-driven, randomized, double-blind, placebo-controlled study in patients hospitalized for heart failure and having an LVEF of 40% or less. A total of 4133 patients were enrolled at 359 North American, South American, and European sites between October 7, 2003, and February 3, 2006. After excluding 1029 patients with a pacemaker, implantable cardioverter-defibrillator, or both at enrollment and 142 patients without a reported baseline QRS duration, 2962 patients were included in the analysis: 1641 had a normal QRS duration (< 120 ms) and 1321 had a prolonged QRS duration (> or = 120 ms). Dual primary end points were all-cause mortality and the composite of cardiovascular death or hospitalization for heart failure. During a median follow-up of 9.9 months, all-cause mortality was 18.7% for patients with a normal baseline QRS duration and 28.1% for patients with a prolonged baseline QRS duration (hazard ratio [HR], 1.61; 95% confidence interval [CI], 1.38-1.87). The composite of cardiovascular death or hospitalization for heart failure was 32.4% for patients with a baseline QRS duration less than 120 ms and 41.6% for patients with a baseline QRS duration of 120 ms or greater (HR, 1.40; 95% CI, 1.24-1.58). The increased risk associated with prolonged QRS duration was confirmed after adjusting for multiple variables for all-cause mortality (HR, 1.24; 95% CI, 1.02-1.50) and the composite of cardiovascular death or hospitalization for heart failure (HR, 1.28; 95% CI, 1.10-1.49). Only 105 patients (3.6%) who presented with a prolonged baseline QRS duration had a normal QRS duration on their last inpatient electrocardiogram. A prolonged QRS duration appears common in patients with reduced LVEF who are hospitalized for heart failure and is an independent predictor of high postdischarge morbidity and mortality.
    Full-text · Article · Jun 2008 · JAMA The Journal of the American Medical Association
  • [Show abstract] [Hide abstract]
    ABSTRACT: A widened QRS interval is associated with increased mortality in patients with heart failure (HF). However, the prognostic significance of the type of bundle branch block (BBB) pattern in these patients is unclear. The data of 4,102 patients with HF hospitalized during a prospective national survey were analyzed to investigate the association between BBB type and 1-year mortality in 3,737 patients without pacemakers. Right BBB (RBBB) was present in 381 patients (10.2%) and left BBB (LBBB) in 504 patients (13.5%). RBBB and LBBB were associated with increased 1-year mortality on univariate analysis (odds ratio [OR] 1.44, 95% confidence interval [CI] 1.15 to 1.81, and OR 1.20, 95% CI 0.97 to 1.47, respectively). In patients with systolic HF, after adjusting for multiple risk factors, only RBBB was found to be an independent predictor of mortality (RBBB vs no BBB OR 1.62, 95% CI 1.12 to 2.33, and RBBB vs LBBB OR 1.71, 95% CI 1.09 to 2.69). This correlation was stronger in patients with lower left ventricular ejection fractions and was also maintained in patients without acute myocardial infarctions. Analyzing the data for all patients with HF, there was a trend for increased mortality in the RBBB group only (adjusted OR 1.21, 95% CI 0.94 to 1.56). LBBB was not related to mortality in patients with either systolic HF or preserved ejection fractions. In conclusion, RBBB rather than LBBB is an independent predictor of mortality in hospitalized patients with systolic HF. This prognostic marker could be used for risk stratification and the selection of treatment.
    No preview · Article · Jun 2008 · The American Journal of Cardiology
  • [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND: Little is known about the prevalence of bundle branch block (BBB) and its association with other cardiovascular disease (CVD) risk factors in the general population. The present study aims to describe the prevalence and examine this association using data from the US National Health and Nutrition Examination Survey (NHANES-III) and 1990 Japan National Survey on Circulatory Disorders. METHODS: A cross-sectional analytical study design was used in the study with a focus on the differences in the prevalence of left and right BBB (LBBB and RBBB) and their relation to other CVD risk factors between American and Japanese people aged >/=40 years. RESULTS: (1) Age-adjusted prevalences of LBBB per 1000 population were 5.2 and 1.9 for the US and Japan samples (p<0.001). No significant difference in the prevalence of RBBB was observed between the two population samples (25.3 per thousand vs. 24.2 per thousand). (2) LBBB and RBBB were significantly associated with several other CVD risk factors. (3) Multivariate logistic analyses indicated that LBBB and RBBB were significantly associated with increased age, SBP, glomerular filtration rate (GFR), and sex and BMI (for RBBB only) in the US sample. Significant relations of LBBB to age, history of stroke and diabetes; and of RBBB to age, sex, total protein and GFR were observed in the Japanese sample. CONCLUSION: The American sample has significantly higher prevalence of LBBB than the Japanese sample. BBB is strongly associated with several other CVD risk factors, but the strengths of these associations are different between the US and Japan samples.
    No preview · Article · Jan 2009 · International journal of cardiology
Show more